RxDoctor Payments Data

Heather Loguidice, NP

Family · Wellington, FLNPI 1427010321

Payments from drug & device makers

$2,000in general payments, 2019–2025

Across 105 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$423
  • Novo Nordisk$269
  • Exact Sciences$215
  • Lilly USA, LLC$215
  • Boehringer Ingelheim$163
  • GSK$108
  • plus $606 from 17 others

What the payments were for

  • Food & beverage$1,97599%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,000 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$29,753
Medicare patients
160
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide11$12,406
Rosuvastatin Calcium77$1,572
SynthroidLevothyroxine Sodium13$1,191
Losartan Potassium94$1,119
Amlodipine Besylate77$618
Atorvastatin Calcium67$564
Gabapentin20$558
Simvastatin35$393
Escitalopram Oxalate22$368
Levothyroxine Sodium65$348
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide19$338
Nebivolol Hcl11$327
Omeprazole17$262
Pantoprazole Sodium21$251
Fluoxetine Hcl12$237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$269$12,40611 claims
AbbVieSynthroid$423$1,19113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.

Other family in Wellington

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →